High abundant protein removal from rodent blood for biomarker discovery. by Haudenschild, Dominik R et al.
UC Davis
UC Davis Previously Published Works
Title
High abundant protein removal from rodent blood for biomarker discovery.
Permalink
https://escholarship.org/uc/item/53f4v1b7
Journal
Biochemical and biophysical research communications, 455(1-2)
ISSN
0006-291X
Authors
Haudenschild, Dominik R
Eldridge, Angela
Lein, Pamela J
et al.
Publication Date
2014-12-01
DOI
10.1016/j.bbrc.2014.09.137
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Biochemical and Biophysical Research Communications 455 (2014) 84–89Contents lists available at ScienceDirect
Biochemical and Biophysical Research Communications
journal homepage: www.elsevier .com/locate /ybbrcHigh abundant protein removal from rodent blood for biomarker
discoveryhttp://dx.doi.org/10.1016/j.bbrc.2014.09.137
0006-291X/ 2014 Elsevier Inc. All rights reserved.
Abbreviations: TCA, trichloroacetic acid; SDS–PAGE, sodium dodecyl sulfate
polyacrylamide gel electrophoresis; 2-DE, two dimensional electrophoresis; 2-D
DIGE, two-dimensional difference gel electrophoresis; MARS, Multiple Afﬁnity
Removal system; PBS, phosphate buffered saline.
⇑ Corresponding author.
E-mail address: bachromy@ucdavis.edu (B.A. Chromy).Dominik R. Haudenschild a, Angela Eldridge b, Pamela J. Lein c, Brett A. Chromy b,⇑
aDepartment of Orthopaedic Surgery, School of Medicine, University of California, Davis, United States
bDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Davis, United States
cDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, United States
a r t i c l e i n f oArticle history:
Received 9 September 2014
Available online 24 October 2014
Keywords:
Proteomics
Plasma
Afﬁnity chromatography
MARS
2-D DIGE
Albumina b s t r a c t
In order to realize the goal of stratiﬁed and/or personalized medicine in the clinic, signiﬁcant advances in
the ﬁeld of biomarker discovery are necessary. Adding to the abundance of nucleic acid biomarkers being
characterized, additional protein biomarkers will be needed to satisfy diverse clinical needs. An appropri-
ate source for ﬁnding these biomarkers is within blood, as it contains tissue leakage factors as well as
additional proteins that reside in blood that can be linked to the presence of disease. Unfortunately, high
abundant proteins and complexity of the blood proteome present signiﬁcant challenges for the discovery
of protein biomarkers from blood. Animal models often enable the discovery of biomarkers that can later
be translated to humans. Therefore, determining appropriate sample preparation of proteomic samples in
rodent models is an important research goal. Here, we examined both mouse and rat blood samples
(including both serum and plasma), for appropriate high abundant protein removal techniques for
subsequent gel-based proteomic experiments. We assessed four methods of albumin removal: anti-
body-based afﬁnity chromatography (MARS), Cibacron Blue-based afﬁnity depletion (SwellGel Blue
Albumin Removal Kit), protein-based afﬁnity depletion (ProteaPrep Albumin Depletion Kit) and TCA/ace-
tone precipitation. Albumin removal was quantiﬁed for each method and SDS–PAGE and 2-DE gels were
used to quantify the number of protein spots obtained following albumin removal. Our results suggest
that while all four approaches can effectively remove high abundant proteins, antibody-based afﬁnity
chromatography is superior to the other three methods.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Difﬁculties in sample preparation currently limit the discovery
of protein biomarkers from bioﬂuids, in particular blood plasma
and serum. One of the biggest challenges in the study of blood
plasma involves the broad concentration range of its protein
constituents. In humans, there is approximately a 109 order of
magnitude from most to least abundant proteins [1]. In addition,
few high abundant proteins dominate the plasma, making bio-
marker discovery of lower abundance proteins even more difﬁcult.
For example, twenty-two proteins comprise over 90% of the total
protein mass in human serum and albumin alone accounts for over50%. These dominant species prevent the detection of lower-
abundance proteins that may be of greater interest as putative
biomarkers [2]. Therefore, a successful system of proteomic sample
preparation to remove these high abundant proteins is needed to
examine lower abundant proteins of interest and to reduce the
complexity for improved biomarker discovery. Researchers have
developed successful ways to remove these proteins, but these
methods vary in the efﬁciency and mechanism for removing
targeted highly abundant proteins [3–7].
Putative protein biomarkers discovered after the removal of
high abundant proteins may serve to detect diseases earlier with
higher accuracy, but may prove to be challenging for subsequent
validation in humans. Therefore, animal models are necessary to
validate these biomarkers and for the discovery of additional
biomarkers. Initial 2-DE proteome maps of mouse and rat pro-
duced species speciﬁc patterns and showed serum proteins can
vary substantially [8–11]. However, these samples have a similar
wide dynamic range in protein concentrations as seen in human
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challenges. Since the same high abundant proteins are found in
blood of animals, their removal from these models is also neces-
sary. There are many ways to accomplish high abundant protein
removal for rodent blood including hydrophobic interactions
[12], ammonium sulfate precipitation [13], ion exchange [10],
antibody-based afﬁnity chromatography [14,15], and TCA/acetone
precipitation [16], and these approaches have been used to enable
discovery of putative biomarkers [15,17–20]. In one of these stud-
ies, plasma protein biomarkers found in a mouse model of pancre-
atic cancer were used to translate to human protein orthologs,
providing putative early detection markers applicable to human
cancer [15]. These studies have focused on a single technique
and have not directly compared removal methods to each other
using the same samples. Moreover, each study has not compared
these techniques for both serum and plasma obtained from both
mice and rats.
In this study, four different methods for high abundant protein
removal were compared using rat serum/plasma and mouse
serum/plasma. SDS–PAGE was used to compare the extent of
albumin removal between these methods. Further characterization
using 2-D DIGE was done to assess the improvement in total pro-
tein spots after removal of high abundant proteins by each of the
four different methods.2. Materials and methods
2.1. Sample collection
Rodent blood was collected under IACUC protocols for (DH) and
(PL). For mice, whole blood was collected by ocular bleed. For rats,
blood was collected from the saphenous vein on the inside of the
thigh using a 21 gauge needle. Serum was allowed to clot at room
temperature for 2–5 h followed by centrifugation at 5000g for
10 min. The supernatant was collected and stored at 80 C in
fresh tube. For plasma, blood was collected into BD 0.5 ml micro-
tainer tubes containing Potassium EDTA (Becton Dickinson, Frank-
lin Lakes, NJ). Blood was centrifuged at 15,000g for 10 min to
separate the plasma from the red blood cells. Plasma was collected,
aliquoted and stored at 80 C until analysis.2.2. High abundant protein removal
Depletion of high abundant proteins was carried out according
to the manufacturer’s instructions with minor modiﬁcations as
detailed below. TCA/acetone was carried out similarly as previ-
ously published [16]. TCA was dissolved in water to make a 20%
solution and this solution was diluted 1:1 with the protein sample
on ice for 30 min. Following incubation the proteins were centri-
fuged and the protein pellet was washed 2 with ice-cold acetone.
The ProteaPrep procedure was carried out as described in the
manufacturer’s protocol (Protea). Protein samples were diluted in
sample buffer 1:4 and then loaded into pre-packed columns con-
taining a proprietary dry powder that facilitated non-antibody,
afﬁnity-based serum albumin removal. The capture ligand is a
recombinant protein that claims to be more speciﬁc than an anti-
body-based system with stronger binding constants. For SwellGel
Blue Albumin (Pierce), 40 ll samples of plasma or serum were
diluted into 160 ll of bind/wash buffer. Albumin binding incuba-
tions were done for 2 min (twice). Incubations were washed 3
times with 200 ll. The ﬂow through and washes were pooled as
the albumin removed sample. For antibody-afﬁnity chromatogra-
phy using the MARS MS-3 (Agilent Technologies), rodent plasma
or serum was diluted ﬁve times in Buffer A (40 ll sample and
160 ll of buffer, 200 ll total volume) and centrifuged through a0.22 micron spin ﬁlter tube (Millipore) at 16,000g for 5 min to
remove particulates. Then, plasma or serum was processed using
4.6  50 mm Multiple Afﬁnity Removal Column Mouse-3 (Agilent
Technologies), which speciﬁcally removes albumin, IgG, and
transferrin. A low abundant protein fraction was collected for each
sample. Fractions were concentrated by precipitating with an
equal volume of 20% TCA solution and incubated at 4 C for
30 min. Precipitate was spun down and washed twice with cold
100% acetone, allowed to air dry and then resuspended in DIGE
labeling buffer (7 M urea, 2 M thiourea, 4% CHAPS, 30 mM Tris,
pH 8.5). Protein quantiﬁcation was performed using Precision
Red Advanced Protein Assay Reagent (Cytoskeleton).2.3. SDS–PAGE
Crude and high abundant protein depleted plasma or serum
samples (5 lg) were mixed with 5 sample loading buffer (0.2 M
Tris pH 6.8, 20% glycerol, 10% SDS, 5% BME), boiled for 10 min at
100 C and resolved on a 4–20% Tris–Glycine gel (Invitrogen). Gels
were stained for total protein using Sypro Ruby Protein Gel Stain
(Invitrogen, S-12000) and visualized using the BioChemi system
(UVP BioImaging Systems).2.4. 2-D DIGE
Crude and high abundant protein depleted plasma and serum
samples were separated in two dimensions using the GE Life
Sciences Ettan DIGE system protocol. Brieﬂy, each sample (50 lg)
was minimally labeled with 1 ll of 200 pM Cy2, Cy3 or Cy5 for
30 min. Labeling reactions were stopped by the addition of 1 ll
of 1 mM lysine. The samples were pooled together and added to
rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 1.2%
DeStreak, 1% pharmalytes). A ﬁnal volume of 450 ll sample was
loaded onto 24 cm pH 3–10NL Immobiline DryStrips (GE Life Sci-
ences) and focused by active overnight rehydration, followed by
isoelectric focusing for a total of 62,500 Vhrs. Strips were equili-
brated in SDS equilibration buffer (6 M urea, 30% glycerol, 2%
SDS) for 15 min with 10 mg/ml DTT, then 15 min in fresh buffer
with 25 mg/ml 15 min with IAA, then applied to DIGE gels (GE Life
Sciences) for 2nd dimension separation. The resulting CyDye
labeled protein gels were scanned using 100 micron resolution
on Typhoon 9410 (GE Life Sciences).2.5. Image analysis
Data analysis was carried out using DeCyder 2-D 7.0 software
(GE Life Sciences). Spot detection and abundance quantiﬁcation
was performed using the differential in-gel analysis (DIA) module
of DeCyder. Densitometry, using ImageJ processing program (avail-
able free online at rsb.info.nih.gov/ij/), was performed on selected
albumin bands to determine the percent removed.3. Results
Four different methods were tested for their ability to remove
albumin from both rodent blood samples. Both rat and mouse sam-
ples of plasma and serum were used. SDS–PAGE and 2-DE were
used to evaluate the overall improvements in proteomic sample
preparation following high abundant protein removal. Table 1
shows the recovery of the total protein following these different
methods. Most of the protein remains in the high abundant frac-
tion, but this table shows that the total protein obtained from these
different methods does not vary substantially. Therefore, none of
these methods reduce total protein recovery more than another.
Table 1
Protein recovered after high abundant protein removal is similar among four different
methods. For all methods used for high abundant protein removal, most of the protein
was removed (about 90%). The remaining lower abundant protein samples were
similar in total amount of protein obtained, ranging from 109 to 177 lg. Some
differences between samples were found but further experimentation needs to be
done to ensure these differences are statistically valid.
Sample Start total (lg) Method
SG Protea TCA/Ac MARS
Mouse serum 1960 174 160 152 150
Mouse plasma 1943 172 168 153 109
Rat serum 2082 171 148 177 174
Rat plasma 1942 151 174 137 155
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fer substantially due to sample preparation, we then examined the
protein pattern using SDS–PAGE. We compared samples following
each technique to each other and to raw serum and plasma. Fig. 1Fig. 1. Mouse blood SDS–PAGE. (A) Mouse plasma and serum, post-albumin removal by e
2. SwellGel Blue Albumin 3. ProteaPrep Lane 4: TCA/acetone Lane 5: MARS Ms-3. Crude s
representing the main albumin band. All lanes show increased numbers of protein ban
analysis of percent albumin decrease showed different depletion levels among the four
most albumin for both plasma and serum samples. Percent albumin decrease was calc
percent albumin found in each crude sample.
Fig. 2. Rat blood SDS–PAGE. (A) Rat plasma and serum, post-albumin removal by each
SwellGel Blue Albumin 3. ProteaPrep Lane 4: TCA/acetone Lane 5: MARS Ms-3. Crude sa
representing the main albumin band. All lanes show increased numbers of protein ban
analysis of percent albumin decrease showed different depletion levels among the four
most albumin for both plasma and serum samples. Percent albumin decrease was calc
percent albumin found in each crude sample.shows SDS–PAGE images for both serum and plasma frommice. All
methods were able to reduce the amount of albumin and increase
the overall number of protein bands that could be detected. Albu-
min depletion strategies for rat serum and plasma showed similar
results with decreased albumin and increased total protein spots
(Fig. 2). The albumin removal results suggest that all methods
chosen for study here can improve the proteomic spot pattern.
However, important differences between techniques were found.
For example, the method that removed the most albumin for
mouse plasma was the antibody-based afﬁnity chromatography,
as it removed about twice as much albumin in some cases
(Table 2).
Another issue for improved biomarker discovery using proteo-
mics involves the concentration of the protein sample and the
use of buffer exchange to ensure proper buffer conditions for sub-
sequent proteomic analysis following high abundant protein
removal. Speciﬁcally, after high abundant protein removal usingach method, was evaluated by SDS–PAGE. Lane 1 crude plasma (left); serum (right).
amples show a few protein bands and the presence of a dark band at roughly 70 kDa
ds and a lower main albumin band following albumin removal. (B) Densitometry
tested methods. The antibody-based afﬁnity chromatography method removed the
ulated using the main albumin band density, relative to each lane, divided by the
method, was evaluated by SDS–PAGE. Lane 1 crude plasma (left); serum (right). 2.
mples show a few protein bands and the presence of a dark band at roughly 70 kDa
ds and a lower main albumin band following albumin removal. (B) Densitometry
tested methods. The antibody-based afﬁnity chromatography method removed the
ulated using the main albumin band density, relative to each lane, divided by the
Fig. 3. Mouse blood 2-D DIGE. (A) Albumin depleted mouse plasma and (B) serum. 2-D DIGE gel images are shown with corresponding number of detected protein spots. The
antibody-based afﬁnity chromatography method removed the most albumin for both plasma and serum samples.
Table 2
Different sample preparation techniques yield signiﬁcant albumin removal with different total protein spots. For all four sample types, antibody-based afﬁnity chromatography
proved to be the best technique for albumin removal and increased protein spots found in a 2D gel. For (A) mouse plasma/serum and (B) rat serum, TCA/acetone method provides
the second most albumin removal and yields the second most 2-D gel spots.
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differences between TCA precipitation and molecular weight cutoff
in this subsequent concentration and buffer exchange step. SDS–
PAGE was used to compare the two procedures (Supplemental
Fig. 1). SDS–PAGE showed very similar banding patterns for both
procedures, following the 3 different types of high abundant
removal protocols. Since TCA/acetone and molecular weight cutoff
removal were found to be similar, TCA/acetone was chosen for
subsequent proteomic analysis.
To determine if a more sensitive proteomic technique could
differentiate among these high abundant protein removal
procedures, we used 2-D DIGE. Fig. 3 shows 2-D DIGE images ofthe mouse serum and plasma samples following high abundant
protein removal. Successful high abundant protein removal is
demonstrated by the increased number of total spots and diverse
spot pattern as compared to crude serum and plasma. The
antibody-based afﬁnity chromatography method showed signiﬁ-
cantly better albumin removal and more total protein spots for
both mouse sample types. The three other methods removed sub-
stantial albumin and had similar numbers of total protein spots,
but each had roughly half of the albumin removal and 200–300
fewer protein spots than the afﬁnity chromatography.
Fig. 4 shows similar results of improved proteomic separation
for rat plasma. Again, antibody-based afﬁnity chromatography
Fig. 4. Rat blood 2-D DIGE. (A) Albumin depleted rat plasma and (B) serum. 2-D DIGE gel images are shown with corresponding number of detected protein spots. Similar to
the mouse blood data, antibody-based afﬁnity chromatography shows the highest number of protein spots, speciﬁcally in the lower half of the gel.
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niques, which were similar with respect to the amount of albumin
removed. Total protein spots were also highest for the afﬁnity
chromatography by at least 100 spots. Over 1200 protein spots
were found following the removal of the top three serum/plasma
proteins using afﬁnity chromatography. Even though this antibody
column was optimized for mouse, the results shown here clearly
demonstrate that the column can be useful for removal of high
abundant rat serum/plasma proteins.
Table 2 shows the results of the albumin removal and the total
protein spots found for all four sample types for all four albumin
depletion methods, showing percent albumin decrease for each
technique used. To validate which techniques removed substantial
albumin, the amount of albumin that was removed was quantiﬁed
using densitometry of the SDS–PAGE. These data show that
antibody-based afﬁnity chromatography removes the most
albumin and shows the greatest number of total protein spots by
a signiﬁcant amount.4. Discussion
Successful proteomic sample preparation from blood often
requires high abundant protein removal. High abundant proteins
have been shown to be responsible for concealing putative mark-
ers. For example, albumin was found to obscure sex differences
in blood plasma of rats and humans [2]. A failure to effectively
remove high abundant proteins can also result in failed or incom-
plete biomarker studies. To determine the optimal protocol for
subsequent biomarker discovery, we completed four methods of
high abundant protein removal for both rat and mouse serum
and plasma. Our results clearly show that antibody-based afﬁnity
chromatography is the superior method for this approach, similar
to results we previously showed for human serum [3].
Several reports in the literature have addressed the issue of
serum complexity and proteomic analyses. Pieper and co-workers
used immunoafﬁnity subtraction chromatography to remove 10
proteins from human blood plasma. Following protein depletion,
Coomassie blue stained 2-dimensional electrophoresis (2-DE) gels
revealed approximately 650 protein spots compared with only 220
spots visible in a sample of crude serum. Silver staining of the pro-
tein-depleted sample revealed an even larger number, 950 spots
[9]. Chan and coworkers used an afﬁnity spin tube ﬁlter methodto remove albumin and IgG to enrich for low-abundant cancer bio-
markers in serum. Over 250 potential biomarkers for breast cancer
were identiﬁed in this study. TCA-acetone has been used to remove
albumin from serum [5]. Finally, Steel and co-workers also used an
immunoafﬁnity resin to remove albumin and IgG from human
serum samples in order to simplify the serum proteome [21].
Our data demonstrate that antibody-based afﬁnity chromatogra-
phy removes the greatest percentage of albumin and results in
the highest total number of lower abundant protein spots relative
to any published work to date. We used 2-D DIGE [3], which can
detect protein spots as low as 150–500 pg of a single protein, with
a linear response in protein concentration over ﬁve orders of mag-
nitude [22]. This method allowed us to detect over 1200 protein
spots in each of these four rodent samples, by far the most protein
spots detected for these sample types.
Antibody-based afﬁnity chromatography often is the best
choice for high abundant protein removal as we showed here for
rodent samples. Importantly, since this column was designed using
mouse antibodies, it was not clearly evident that it would work
well with rat samples. However, our work shows that both rat
serum and plasma can be improved for biomarker discovery using
this approach. The speciﬁcity and efﬁciency of the microbead, IgY-
based anti-rat immunoafﬁnity LC column has been previously
examined and has improved protein detection using several differ-
ent techniques including SELDI-TOF MS, 2-dimensional SDS–PAGE,
and 2-dimensional liquid chromatography [14]. Although results
here show more protein spots, we do not know if this is because
of the relative improvement of the column used here or the highly
sensitive visualization technique of 2-D DIGE, which is also high-
lighted as integral for improved protein biomarker identiﬁcation
[14]. Future work should be done to see if species speciﬁc
antibodies improve upon the results found here. Species-speciﬁc
differences may also explain why the ProteaPrep depletion kit
was not better than antibody-afﬁnity despite claims to that the
recombinant protein capture ligand is more efﬁcient than anti-
body-based methods. The ProteaPrep capture ligand is claimed to
be more speciﬁc than antibodies and has a stronger binding con-
stant to human serum albumin. The results here do not support
this, which might be due to species-speciﬁc differences. Further
investigation into human albumin removal is necessary to com-
pare these removal methods.
In addition, we showed that TCA precipitation enables the
complete removal of buffer for both concentration and exchange
D.R. Haudenschild et al. / Biochemical and Biophysical Research Communications 455 (2014) 84–89 89purposes for these sample types. TCA precipitation has been widely
used to concentrate protein samples and exchange existing buffers
in proteomic sample preparation [23]. However, protein is
denatured following TCA precipitation, so protein activity cannot
be assessed. In addition, proteins cannot be resuspended easily in
any non-denaturing buffer (such as PBS). Molecular weight cutoff
membranes have also been widely used for concentration and
buffer exchange. Molecular weight membranes enable the removal
of buffer by centrifugation through ﬁltration, while retaining pro-
teins of at least 3 kDa. This procedure offers a single step sample
concentration in a single tube for minimal sample handling and
reduced sample loss. When comparing a single TCA/acetone step
with molecular weight cutoff membranes following other types
of high abundant protein removal, we did not notice substantial
differences (Supplementary Fig. 1).
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